Purchase non-invasive backscatter (nibs) dynamic light scattering/multi-angle dynamic light scattering (madls) system (zetasizer ultra red label)

Ended Awarded

Contract number
75F40121F80230
Awardee
Awarding agency
Obligated
$86,378

Award facts

Contract value 100% obligated
$86,378.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Leesburg, VA, USA

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a delivery order to Samyak Solutions, Inc., an 8(a) Program Participant and Economically Disadvantaged Women-Owned Small Business located in Centreville, Virginia, for the purchase of a Non-Invasive Backscatter Dynamic Light Scattering/Multi-Angle Dynamic Light Scattering (MADLS) system, specifically a Zetasizer Ultra Red Label instrument. The contract, valued at $86,378.34 on a firm fixed-price basis, was awarded on July 16, 2021, with a completion date of November 26, 2021. Performance will take place in Leesburg, Virginia. This delivery order was issued under the General Services Administration's Multiple Award Schedule (MAS) and did not utilize a set-aside designation.

The Zetasizer Ultra Red Label is an advanced analytical instrument used for particle characterization and size distribution analysis, which aligns with the FDA's mission in supporting pharmaceutical development, quality control, and regulatory compliance activities. Samyak Solutions brings substantial experience in supplying sophisticated scientific equipment to federal agencies, holding significant Indefinite Delivery Vehicles including a $500 million contract with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense and a $10 million Blanket Purchase Agreement with the National Institutes of Health. The company's certifications as a HUBZone firm, Women-Owned Small Business, and 8(a) participant reflect its standing within the federal small business contracting community.

Quick answers

Who was awarded contract 75F40121F80230?

75F40121F80230 was awarded to Samyak Solutions, Inc. by Food and Drug Administration (Department of Health and Human Services) on July 16, 2021.

How much is contract 75F40121F80230 worth?

The government has obligated $86,378 on 75F40121F80230.

Is contract 75F40121F80230 an order under another contract?

Yes. 75F40121F80230 is a delivery order under GS07F052BA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40121F80230 competed?

The extent of competition for 75F40121F80230 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award